Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Logitech International SA (LOGI) Price & Performance

Cassava Sciences IncTrade
Logitech International SATrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Logitech International SA — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Logitech International SA trades at $103.79 (market cap $14.96B). The key difference: Logitech International SA is far larger — about 313.3× Cassava Sciences Inc's market cap, and Logitech International SA pays a 1.64% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FLNALOGI
Market Cap
$47.75M$14.96B
Sector
HealthTechnology
52-Week High
$4.64$126.69
52-Week Low
$0.87$85.84
Enterprise Value
-$34.93M$13.30B
Dividend Yield
1.64%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA is trading at $0.9401, down 5.74% on the day, with a bearish technical signal from moving averages. The company shows consistent quarterly earnings beats but remains unprofitable with negative ROE of -55.79% and negative cash flow. Analyst sentiment is positive with 67% buy ratings, though the stock faces fundamental challenges with ongoing operational losses.

The outlook remains challenged by persistent losses and negative cash flow, though recent earnings beats and strong analyst support provide potential upside. Key risks include the company's ability to achieve profitability and sustain operations given current burn rate. The biotechnology focus on TSC-related epilepsy represents both opportunity and execution risk.

Logitech International SA

Logitech (LOGI) trades at $103.28, down 1.52% on the day, with a bearish technical signal and mixed analyst sentiment. Recent Q1 2027 earnings beat expectations with EPS of $1.85 versus $1.26 expected, driven by tariff refunds and premium demand. However, a semiconductor supplier shutdown poses near-term supply chain risks. The stock shows strong profitability with a net margin of 16.28% and ROE of 35.29%, but valuation multiples like P/E of 19.03 and P/S of 3.1 suggest moderate pricing.

Outlook is cautious due to supply constraints overshadowing solid fundamentals. The consensus price target is $109.75, offering ~6% upside, but investor sentiment is divided with equal buy and sell ratings. Key risks include execution on supply chain mitigation and competitive pressures in the gaming and peripherals market. Near-term performance hinges on resolving supplier issues to meet robust demand.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Logitech International SA

Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.

Read more on LOGI